Opus Genetics (IRD) CFO Robert Gagnon Sells 7,783 Shares

What Happened
Robert E. Gagnon, Chief Financial Officer of Opus Genetics (IRD), had 7,783 shares disposed of on July 23, 2026 at a weighted average price of $2.95 per share, yielding gross proceeds of $22,942. The Form 4 filed July 27, 2026 shows these shares were sold (transaction code S) to satisfy tax withholding obligations tied to a restricted stock unit (RSU) vesting/settlement event.

Key Details

• Transaction date: 2026-07-23; Form 4 filed: 2026-07-27 (filed four days after the transaction). Form 4 is typically due within two business days, so this filing appears late.
• Price: weighted average $2.95; sale prices ranged from $2.9006 to $3.025 (footnote F2).
• Shares sold: 7,783; proceeds: $22,942.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote F1: sale was automatic to satisfy tax withholding related to RSU vesting — not a discretionary trade by the insider.
• Footnote F2: weighted-average price reported; the filer will provide a per-price breakdown on request.

Context
This was a tax-withholding sale following an RSU vest/settlement — a routine, non-discretionary disposition that generally reflects tax mechanics rather than insider sentiment. Retail investors typically treat such withholding sales as neutral, not as a strategic sell signal.